The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
The Signaling Adaptor p62 Is an Important NF-κB Mediator in Tumorigenesis
Open accessAbstract
The balance between cell death and survival, two critical aspects of oncogenic transformation, determines the outcome of tumorigenesis. Nuclear factor-kappaB (NF-kappaB) is a critical regulator of survival; it is induced by the oncogene Ras and, when inhibited, accounts for the cell death response of Ras-transformed cells. Here, we show that the signaling adaptor p62 is induced by Ras, its levels are increased in human tumors, and it is required for Ras-induced survival and transformation. p62-/- mice are resistant to Ras-induced lung adenocarcinomas. p62 is necessary for Ras to trigger IkappaB kinase (IKK) through the polyubiquitination of tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6), and its deficiency produces increased reactive oxygen species (ROS) levels, which account for the enhanced cell death and reduced tumorigenicity of Ras in the absence of p62.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ALS-associated mutations in TBK1, OPTN, SQSTM1, and VCP all affect autophagy as well as microglial function and innate immunity [192,205,206,441–443].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [442]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc969 · Cited by 3,354
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
RAS oncogenes: the first 30 years
Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Ubiquitin signalling in the NF-κB pathway
Chen, Z. J. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-758 · Cited by 1,184
Maeda, S., Kamata, H., Luo, J., Leffert, H. L., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,160
Flagged first, then by citations
1 of the 51 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 543
Chang, K. H., Sengupta, A., Nayak, R. C., Durán, Á., Lee, S. J., Pratt, R. G., Wellendorf, A. M., Kargbo-Hill, S. E., Watkins, M. P., González‐Nieto, D., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.031 · Cited by 62
Self-citationLam, H. C., Baglini, C. V., Lope, A. L., Parkhitko, A. A., Liu, H.-J., Alesi, N., Malinowska, I. A., Ebrahimi‐Fakhari, D., Saffari, A., Yu, J. J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2458 · Cited by 63
Self-citationThe Tripartite Nexus: Autophagy, Cancer, and Tripartite Motif-Containing Protein Family Members
Mandell, M. A., Saha, B., & Thompson, T. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00308 · Cited by 61
NF-κB and its crosstalk with endoplasmic reticulum stress in atherosclerosis
Li, W., Jin, K., Luo, J., Xu, W., Wu, Y., Zhou, J., Wang, Y., Xu, R., Jiao, L., Wang, T., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.988266 · Cited by 68
Luo, M. X. M., Wong, S. H., Chan, M. T. V., Yu, L., Yu, S. S. B., Wu, F., Xiao, Z., Wang, X., Zhang, L., Cheng, A. S. L., et al. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24967 · Cited by 63
CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer
Xu, W., Wei, Q., Han, M., Zhou, B., Wang, H., Zhang, J., Wang, Q., Sun, J., Feng, L., Wang, S., et al. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.25349 · Cited by 64
Adiponectin restrains ILC2 activation by AMPK-mediated feedback inhibition of IL-33 signaling
Wang, L., Luo, Y., Luo, L., Wu, D., Ding, X., Zheng, H., Wu, H., Liu, B., Yang, X., Silva, F. D., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191054 · Cited by 58
Karras, P., Riveiro‐Falkenbach, E., Cañón, E., Tejedo, C., Calvo, T. G., Martínez-Herranz, R., Alonso‐Curbelo, D., Cifdaloz, M., Pérez‐Guijarro, E., Goméz-López, G., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.11.008 · Cited by 64
Self-citationCD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis
Tsoyi, K., Liang, X., Rossi, G. D., Ryter, S. W., Xiong, K., Chu, S. G., Liu, X., Ith, B., Celada, L. J., Romero, F., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202008-3100oc · Cited by 60
Yang, S., Qiang, L., Sample, A., Shah, P., & He, Y. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.756536 · Cited by 63
Liver autophagy: physiology and pathology
Komatsu, M. (2012) · The Journal of Biochemistry · doi:10.1093/jb/mvs059 · Cited by 61
Yan, X., Zhang, Y., Zhang, J., Zhang, L., Liu, Y., Wu, Y., Xue, Y., Lu, S., Su, J., & Sun, L. (2017) · Cancer Science · doi:10.1111/cas.13276 · Cited by 59
Sirt1 deacetylates and stabilizes p62 to promote hepato-carcinogenesis
Feng, L., Chen, M., Li, Y., Li, M., Hu, S., Zhou, B., Zhu, L., Yu, L., Zhou, Q., Tan, L., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03666-z · Cited by 57
IKK/Nuclear Factor-kappaB and Oncogenesis
Bradford, J. W., & Baldwin, A. S. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800249-0.00003-2 · Cited by 58
Chemical and genetic control of IFNγ‐induced MHCII expression
Wijdeven, R. H. M., van Luijn, M. M., Wierenga‐Wolf, A. F., Akkermans, J. J. L. L., van den Elsen, P. J., Hintzen, R. Q., & Neefjes, J. (2018) · EMBO Reports · doi:10.15252/embr.201745553 · Cited by 59
Prognostic relevance of autophagy markers LC3B and p62 in esophageal adenocarcinomas
Adams, O. J., Dislich, B., Berezowska, S., Schläfli, A. M., Seiler, C. A., Kröll, D., Tschan, M. P., & Langer, R. (2016) · Oncotarget · doi:10.18632/oncotarget.9649 · Cited by 59
Zhang, J., Zhang, C. M., Jiang, X., Li, L., Zhang, D., Tang, D., Yan, T., Zhang, Q., Yuan, H., Jia, J., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1473-9 · Cited by 58
RetractedCervigne, N. K., Machado, J. C., Goswami, R. S., Sadiković, B., Bradley, G., Perez‐Ordoñez, B., Galloni, N. N., Gilbert, R. W., Gullane, P. J., Irish, J. C., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt657 · Cited by 56
Wang, X., Du, Z., Li, L., Shi, M., & Yu, Y. (2015) · PubMed Central · Cited by 56
Sequestosome 1/p62: A multitasker in the regulation of malignant tumor aggression (Review)
Tang, J., Li, Y., Xia, S., Li, J., Yang, Q., Ding, K., & Zhang, H. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5257 · Cited by 57
Tazawa, H., Yano, S., Yoshida, R., Yamasaki, Y., Sasaki, T., Hashimoto, Y., Kuroda, S., Ouchi, M., Onishi, T., Uno, F., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27589 · Cited by 63
Xia, Y., Liu, Y.-L., Xie, Y., Zhu, W., Guerra, F., Shen, S., Yeddula, N., Fischer, W. H., Low, W., Zhou, X., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3010382 · Cited by 55
Xu, Y., Liao, C., Liu, R., Liu, J., Chen, Z., Zhao, H., Li, Z., Chen, L., Wu, C.-P., Tan, H. Q., et al. (2018) · Cell Biology International · doi:10.1002/cbin.11061 · Cited by 55
Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector
Venanzi, F. M., Shifrin, V. I., Sherman, M. Y., Gabai, V. L., Киселев, О. И., Komissarov, A. B., Grudinin, M. P., Shartukova, M., Romanovskaya-Romanko, E., Kudryavets, Y., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1397 · Cited by 54
Kjær, S., Linch, M. D., Purkiss, A. G., Kostelecky, B., Knowles, P. P., Rossé, C., Riou, P., Soudy, C., Kaye, S. J., Patel, B., et al. (2013) · Biochemical Journal · doi:10.1042/bj20121871 · Cited by 58
Strohecker, A. M., Joshi, S., Possemato, R., Abraham, R. T., Sabatini, D. M., & White, E. (2015) · Oncogene · doi:10.1038/onc.2015.23 · Cited by 55
Chen, Y., Li, Q., Li, Q., Xing, S., Liu, Y., Liu, Y., Chen, Y., Liu, W., Feng, F., & Sun, H. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02038 · Cited by 56
de Castro, J., García, R., Garrido, P., Isla, D., Massutí, B., Blanca, B., & Vázquez, J. (2015) · Clinical Lung Cancer · doi:10.1016/j.cllc.2015.06.004 · Cited by 53
Manara, E., Baron, E., Tregnago, C., Aveic, S., Bisio, V., Bresolin, S., Masetti, R., Locatelli, F., Basso, G., & Pigazzi, M. (2014) · Blood · doi:10.1182/blood-2013-09-525741 · Cited by 51
Autophagy in Plasma Cell Ontogeny and Malignancy
Milan, E., Fabbri, M., & Cenci, S. (2016) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0254-9 · Cited by 54
p62/SQSTM1 in liver diseases: the usual suspect with multifarious identities
Tan, C. T., Soh, N. J. H., Chang, H., & Yu, V. C. K. (2021) · FEBS Journal · doi:10.1111/febs.16317 · Cited by 52
The receptor proteins: pivotal roles in selective autophagy
Xu, Z., Yang, L., Xu, S., Zhang, Z., & Cao, Y. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv055 · Cited by 57
Chao, A., Lin, C., Chao, A., Tsai, C.-L., Chen, M., Lee, L., Chang, T., Wang, T., Lai, C., & Wang, H. (2017) · Oncotarget · doi:10.18632/oncotarget.20158 · Cited by 51
The Multifunctional Protein p62 and Its Mechanistic Roles in Cancers
Ning, S., & Wang, L. (2018) · Current Cancer Drug Targets · doi:10.2174/1568009618666181016164920 · Cited by 55
Patulin induces pro-survival functions via autophagy inhibition and p62 accumulation
Guo, X., Dong, Y., Yin, S., Zhao, C., Huo, Y., Fan, L., & Hu, H. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.349 · Cited by 51
Pathophysiological Role of Autophagy: Lesson from Autophagy-Deficient Mouse Models
Ichimura, Y., & Komatsu, M. (2011) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.60.329 · Cited by 50
An Integrated, High-Throughput Strategy for Multiomic Systems Level Analysis
Gutierrez, D. B., Gant-Branum, R. L., Romer, C. E., Farrow, M. A., Allen, J. L., Dahal, N., Nei, Y.-W., Codreanu, S. G., Jordan, A., Palmer, L. D., et al. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00302 · Cited by 50
Obesity, autophagy and the pathogenesis of liver and pancreatic cancers
Aghajan, M., Li, N., & Karin, M. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07008.x · Cited by 48
Role of p62 in the regulation of cell death induction
Fan, L., Yin, S., Zhang, E., & Hu, H. (2018) · APOPTOSIS · doi:10.1007/s10495-018-1445-z · Cited by 52
Zhen, Z., Ren, S.-H., Ji, H., Ma, J., Ding, X., Feng, F., Chen, S.-L., Zou, P., Ren, J., & Jia, L. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.023 · Cited by 48
Denisenko, T. V., Pivnyuk, A. D., & Zhivotovsky, B. (2018) · Cancers · doi:10.3390/cancers10050148 · Cited by 51
Huang, X., Wang, X., Yuan, X., Wu, W., Lobie, P. E., & Wu, Z. (2018) · Oncogene · doi:10.1038/s41388-018-0513-8 · Cited by 48
TAK1 converts Sequestosome 1/p62 from an autophagy receptor to a signaling platform
Kehl, S. R., Soos, B. A., Saha, B., Choi, S. W., Herren, A. W., Johansen, T., & Mandell, M. A. (2019) · EMBO Reports · doi:10.15252/embr.201846238 · Cited by 49
Benedetti, E., Antonosante, A., d’Angelo, M., Cristiano, L., Galzio, R. J., Destouches, D., Florio, T. M., Dhez, A. C., Astarita, C., Cinque, B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5990 · Cited by 47
STAT3 as a new autophagy regulator
Jonchère, B., Bélanger, A., Guette, C., Barré, B., & Coqueret, O. (2013) · JAK-STAT · doi:10.4161/jkst.24353 · Cited by 48
Bincoletto, C., Bechara, A., Pereira, G. J. S., Santos, C. P., Antunes, F., Peixoto-da-Silva, J., Muler, M. L., Gigli, R. D., Monteforte, P. T., Hirata, H., et al. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.09.018 · Cited by 47
Autophagy in cancer: Having your cake and eating it
Hoare, M., Young, A. R. J., & Narita, M. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.004 · Cited by 47
NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB
Kabacaoğlu, D., Ruess, D. A., Ai, J., & Algül, H. (2019) · Cancers · doi:10.3390/cancers11070937 · Cited by 49
Burdelski, C. M., Reiswich, V., Hube‐Magg, C., Kluth, M., Minner, S. J. P., Koop, C., Graefen, M., Hans Heinzer, A., Tsourlakis, M. C., Wittmer, C., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0620 · Cited by 47
Pun, N. T., & Park, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-00456-6 · Cited by 47
The pleiotropic functions of autophagy in metastasis
Marsh, T., Tolani, B., & Debnath, J. (2021) · Journal of Cell Science · doi:10.1242/jcs.247056 · Cited by 49
Tamoxifen activates Nrf2-dependent SQSTM1 transcription to promote endometrial hyperplasia
Feng, L., Li, J., Yang, L., Zhu, L., Huang, X., Zhang, S., Luo, L., Jiang, Z., Jiang, T., Xu, W., et al. (2017) · Theranostics · doi:10.7150/thno.19135 · Cited by 45
Metabolic reprogramming of the tumor microenvironment by p62 and its partners
Reina‐Campos, M., Shelton, P. M., Díaz-Meco, M. T., & Moscat, J. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.010 · Cited by 46
Self-citationMolecular Mechanism of Autophagy and Its Regulation by Cannabinoids in Cancer
Lee, X. C., Werner, E., & Falasca, M. (2021) · Cancers · doi:10.3390/cancers13061211 · Cited by 48
Oxidized low-density lipoprotein regulates macrophage polarization in atherosclerosis
He, Y., & Liu, T. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110338 · Cited by 45
Lipopolysaccharide Stimulates p62-Dependent Autophagy-Like Aggregate Clearance in Hepatocytes
Chen, C., Deng, M., Sun, Q., Loughran, P., Billiar, T. R., & Scott, M. J. (2014) · BioMed Research International · doi:10.1155/2014/267350 · Cited by 42
Shah, P., Trinh, E., Qiang, L., Xie, L., Hu, W., Prins, G. S., Pi, J., & He, Y.-Y. (2017) · Molecules · doi:10.3390/molecules22020194 · Cited by 44
LLPS of SQSTM1/p62 and NBR1 as outcomes of lysosomal stress response limits cancer cell metastasis
Noguchi, T., Sekiguchi, Y., Shimada, T., Suzuki, W., Yokosawa, T., Itoh, T., Yamada, M., Suzuki, M., Kurokawa, R., Hirata, Y., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2311282120 · Cited by 42
Autophagy and SQSTM1 on the RHOA(d) again
Belaïd, A., Ndiaye, P. D., Cerezo, M., Cailleteau, L., Brest, P., Klionsky, D. J., Carle, G. F., Hofman, P. M., & Mograbi, B. (2013) · Autophagy · doi:10.4161/auto.27198 · Cited by 46
Zhang, L., Hu, W., Cho, C. H., Chan, F. K. L., Yu, J. Q., Fitzgerald, J. R., Cheung, C., Xiao, Z. G., Shen, J., Li, L. F., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5033 · Cited by 44
IκB Kinase α Is Required for Development and Progression of KRAS -Mutant Lung Adenocarcinoma
Vreka, M., Lilis, I., Papageorgopoulou, M., Giotopoulou, G. A., Lianou, M., Giopanou, I., Kanellakis, N. I., Σπέλλα, Μ., Agalioti, T., Armenis, V., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1944 · Cited by 40
Liang, Y., Jiang, Y., Jin, X., Chen, P., Heng, Y., Cai, L., Zhang, W., Li, L., & Jia, L. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00576-z · Cited by 41
Autophagy: an adaptable modifier of tumourigenesis
Wilkinson, S., & Ryan, K. M. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.12.004 · Cited by 42
Integrating autophagy and metabolism in cancer
Cheong, H. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0562-2 · Cited by 40
NF-kappaB in Lung Tumorigenesis
Cai, Z., Tchou-Wong, K.-M., & Rom, W. N. (2011) · Cancers · doi:10.3390/cancers3044258 · Cited by 40
AtNBR1 Is a Selective Autophagic Receptor for AtExo70E2 in Arabidopsis
Ji, C., Zhou, J. M., Guo, R., Lin, Y., Kung, C.-H., Hu, S., Ng, Q. W.-Y., Zhuang, X., & Jiang, L. (2020) · PLANT PHYSIOLOGY · doi:10.1104/pp.20.00470 · Cited by 41
Here, There Be Dragons : Charting Autophagy-Related Alterations in Human Tumors
Lebovitz, C. B., Bortnik, S. B., & Gorski, S. M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2465 · Cited by 40
Darvekar, S. R., Elvenes, J., Brenne, H. B., Johansen, T., & Sjøttem, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085262 · Cited by 40
Feasibility Analysis of p62 (SQSTM1)—Encoding DNA Vaccine as a Novel Cancer Immunotherapy
Gabai, V. L., & Shifrin, V. I. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2014.954699 · Cited by 37
Targeting Pathways Downstream of KRAS in Lung Adenocarcinoma
Zhu, Z., Golay, H. G., & Barbie, D. A. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.108 · Cited by 40
Unravelling the relationship between macroautophagy and mitochondrial ROS in cancer therapy
Zhao, Y., Qu, T., Wang, P., Li, X., Qiang, J., Xia, Z., Duan, H., Huang, J., & Zhu, L. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1236-3 · Cited by 40
Meng, W., & Gao, S. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03303-1 · Cited by 39
Role of p62/SQSTM1 beyond autophagy: a lesson learned from drug‐induced toxicity in vitro
Alegre, F., Moragrega, Á. B., Polo, M., Martí-Rodrigo, A., Esplugues, J. V., Blas‐García, A., & Apostolova, N. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14093 · Cited by 39
Li, S., Xiong, P., Zhang, W., Hu, H., Tang, S., Jia, B., & Huang, W. (2022) · Molecules · doi:10.3390/molecules27175622 · Cited by 39
BRAF-induced tumorigenesis is IKKα-dependent but NF-κB–independent
Margalef, P., Colomer, C., Villanueva, A., Montagut, C. O., Iglesias, M., Bellosillo, B., Salazar, R., Martínez‐Iniesta, M., Bigas, A., & Espinosa, L. (2015) · Science Signaling · doi:10.1126/scisignal.2005886 · Cited by 38
Wu, F., Wei, X., Wu, Y., Kong, X., Hu, A., Tong, S., Liu, Y., Gong, F., Xie, L., Zhang, J., et al. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5414 · Cited by 40
Foster, A. D., & Rea, S. L. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.284977 · Cited by 41
Chan, H., Li, Q., Wang, X., Liu, W. Y., Hu, W., Zeng, J., Xie, C., Kwong, T. N. Y., Ho, I. H. T., Liu, X., et al. (2022) · Autophagy · doi:10.1080/15548627.2021.2016004 · Cited by 37
Novel pharmacological modulators of autophagy: an updated patent review (2012-2015)
Ha, J., & Kim, J. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1217996 · Cited by 37
Wang, C., Yeo, S. K., Haas, M. A., & Guan, J. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201609093 · Cited by 40
Control of NAD+ homeostasis by autophagic flux modulates mitochondrial and cardiac function
Zhang, Q., Li, Z., Li, Q., Trammell, S. A. J., Schmidt, M. S., Pires, K. M. P., Cai, J., Zhang, Y., Kenny, H., Boudina, S., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-023-00009-w · Cited by 37
Moon, J.-H., Lee, J., Lee, Y.-J., & Park, S. (2016) · Oncotarget · doi:10.18632/oncotarget.13730 · Cited by 36
ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma
Ndoye, A., Budina-Kolomets, A., Kugel, C. H., Webster, M. R., Kaur, A., Behera, R., Rebecca, V. W., Li, L., Brafford, P. A., Liu, Q., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0907 · Cited by 36
Oncoprotein-specific molecular interaction maps (SigMaps) for cancer network analyses
Broyde, J., Simpson, D. R., Murray, D., Paull, E., Chu, B., Tagore, S., Jones, S. J., Griffin, A. T., Giorgi, F. M., Lachmann, A., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0652-7 · Cited by 33
Ponomarenko, D. M., Клімова, І., Chapygina, Y. A., Dvornichenko, V. V., Zhukova, N. V., Орлова, Р. В., Manikhas, G. M., Zyryanov, A. V., Бурханова, Л. А., Badrtdinova, I. I., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16574 · Cited by 36
IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity
Bassères, D. S. D. S., Ebbs, A., Cogswell, P. C., & Baldwin, A. S. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.5 · Cited by 35
Cai-McRae, X., Zhong, H., & Karantza, V. (2014) · Oncogene · doi:10.1038/onc.2014.244 · Cited by 36
GBP3 promotes glioma cell proliferation via SQSTM1/p62-ERK1/2 axis
Xu, H., Sun, L., Zheng, Y., Yu, S., Ouyang, J., Han, H., Dai, X., Yu, X., Li, M., & Lan, Q. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.050 · Cited by 37
Zhang, J., Yang, S., Xu, B., Wang, T., Zheng, Y., Liu, F., Ren, F., Jiang, J., Shi, H., Zou, B., et al. (2019) · Cell Proliferation · doi:10.1111/cpr.12585 · Cited by 35
Olanzapine induced autophagy through suppression of NF‐κB activation in human glioma cells
Zhu, Y., Zhao, Y., Liu, R., Xiong, Y., Shen, X., Wang, Y., & Liang, Z. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13127 · Cited by 35
Jiang, G., Liang, X., Huang, Y., Lan, Z., Zhang, Z., SU, Z., Fang, Z., Lai, Y., Yao, W., Liu, T., et al. (2020) · Oncology Reports · doi:10.3892/or.2020.7527 · Cited by 37
Kim, M., Min, Y., Im, J. S., Son, J., Lee, J. S., & Lee, K. (2020) · Cells · doi:10.3390/cells9051142 · Cited by 35
Wang, Z., Chen, Q., Li, B., Xie, J., Yang, X., Zhao, K., Wu, Y. G., Ye, Z., Chen, Z., Qin, Z., et al. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.192 · Cited by 36
Genetics and Pharmacology of Longevity
Castillo-Quan, J. I., Kinghorn, K. J., & Bjedov, I. (2015) · Advances in genetics · doi:10.1016/bs.adgen.2015.06.002 · Cited by 37
Pathogen-Induced Autophagy Signaling in Innate Immunity
Faure, M., & Lafont, F. (2013) · Journal of Innate Immunity · doi:10.1159/000350918 · Cited by 37
Kim, Y., Eom, J.-I., Jeung, H.-K., Jang, J. E., Kim, J. S., Cheong, J., Kim, Y. S., & Min, Y. H. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.05.012 · Cited by 34
Tissue Specific Induction of p62/Sqstm1 by Farnesoid X Receptor
Williams, J. A. R., Thomas, A., Li, G., Kong, B., Zhan, L., Inaba, Y., Xie, W., Ding, W., & Guo, G. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043961 · Cited by 33
P62: An emerging oncotarget for osteolytic metastasis
Zhang, J., Yang, Z., & Dong, J. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.01.003 · Cited by 34
Lou, J.-S., Yan, A. L., Bi, C. W. C., Chan, G. K.-L., Wu, Q., Liu, Y.-L., Huang, Y., Yao, P., Du, C. Y. Q., Dong, T. T.-X., et al. (2016) · Scientific Reports · doi:10.1038/srep31926 · Cited by 33
Additive amelioration of ALS by co‐targeting independent pathogenic mechanisms
Frakes, A. E., Braun, L., Ferraiuolo, L., Guttridge, D. C., & Kaspar, B. K. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.375 · Cited by 36
Metadata
- Authors
- Duran, A., Linares, J. F., Galvez, A. S., Wikenheiser, K., Flores, J. M., Diaz-Meco, M. T., & Moscat, J.
- Affiliations
- University of Cincinnati (US)
- Universidad Complutense de Madrid (ES)
- Corresponding author
- Moscat, Jorge
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 13
- Issue
- 4
- Pages
- 343-354
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W1981912182
- Cited by
- 541
- References
- 51
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 13 · 2023: 18 · 2022: 30 · 2021: 35 · 2020: 41 · 2019: 39 · 2018: 41 · 2017: 51 · 2016: 41 · 2015: 38 · 2014: 41 · 2013: 45 · 2012: 29
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Memorial Sloan-Kettering Cancer Center
- Cincinnati Children's Hospital Medical Center
- University of Cincinnati
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- p62, NF-κB signaling, oncogenic Ras, carcinogenesis, cell survival, cell death, TRAF6, IκB kinase, polyubiquitination, reactive oxygen species, lung adenocarcinoma, oncogenic transformation
- MeSH terms
- Animals, Cell Survival, Cell Transformation, Neoplastic, DNA-Binding Proteins, Humans, Lung Neoplasms, Neoplasms, Transcription, Genetic, Signal Transduction, NF-kappa B, RNA-Binding Proteins, Reactive Oxygen Species, ras Proteins, Cell Line, Tumor, Adaptor Proteins, Signal Transducing, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
